Consistent with the findings in the subcutaneous xenograft model, a significant decrease in tumor volume was observed in mice treated with both CYTOR ASO‐1 and CYTOR ASO‐2 as compared to control mice (Figure 8e–g). Here, CYTOR is linked to neoplasm.